Back to Search
JOHN C HERNDON III MD
MD
Anesthesiology Physician
NPI: 1689676744IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
H4399(TX)
Education
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Class of 1987
Research & Publications (20)
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
PMID 19562254·J Neurooncol·2010
3-trial
Medical errors in orthopaedics. Results of an AAOS member survey.
PMID 19255214·J Bone Joint Surg Am·2009
8-other
Quality management of potential chemotherapy-induced neutropenic complications: evaluation of practice in an academic medical center.
PMID 19096882·Support Care Cancer·2009
8-other
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
PMID 19533023·J Neurooncol·2009
3-trial
Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541.
PMID 19170232·Cancer·2009
8-other
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.
PMID 19248046·Cancer·2009
3-trial
Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival.
PMID 19117348·Cancer·2009
8-other
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
PMID 19402172·Cancer·2009
3-trial
"Reproductive aging in captive and wild common chimpanzees: factors influencing the rate of follicular depletion," by S. Atsalis and E. Videan, American Journal of Primatology 71, 271-282 (2009).
PMID 19514043·Am J Primatol·2009
7-preclinical
Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
PMID 19514083·Cancer·2009
8-other
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer.
PMID 19652624·J Thorac Oncol·2009
4-observational
Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer. Cancer and Leukemia Group B 79804.
PMID 19133656·Cancer·2009
8-other
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme.
PMID 19188181·Clin Cancer Res·2009
3-trial
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
PMID 19204199·J Clin Oncol·2009
3-trial
Patient safety in north america: beyond "operate through your initials" and "sign your site".
PMID 19487535·J Bone Joint Surg Am·2009
6-review
No effect of different estrogen receptor ligands on cognition in adult female monkeys.
PMID 19101578·Physiol Behav·2009
4-observational
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
PMID 19289491·Neuro Oncol·2009
3-trial
Exercise and dietary change after diagnosis and cancer-related symptoms in long-term survivors of breast cancer: CALGB 79804.
PMID 18536022·Psychooncology·2009
8-other
Adverse events after total knee arthroplasty: a national Medicare study.
PMID 19577884·J Arthroplasty·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 12222 MERIT DR STE 600
DALLAS, TX 75284 - Phone
- (972) 715-5000
Quick Facts
- NPI
- 1689676744
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile